Palou J, Salvador J, Millán F, Collado A, Algaba F, Vicente J
Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Spain.
J Urol. 2000 Mar;163(3):744-7.
We analyze the evolution of superficial transitional cell carcinoma in the intramural distal ureter treated with transurethral resection.
A total of 19 patients underwent transurethral resection of the intramural distal ureter with a mean followup of 57 months. All cases were diagnosed as superficial transitional cell carcinoma and all but 2 had a history of bladder tumor. Upper urinary tract followup consisted of excretory urography every 6 months and ureterorenoscopy in cases with a doubtful diagnosis or positive cytology.
Pathological examination revealed stage Ta disease in 42%, T1 in 31.5% and Tx in 26.3% of intramural tumors. Upper urinary tract recurrence was noted in 8 patients (42.1%), including 5 (62.5%) with involvement of the distal ureter. Nontumoral stenosis of the distal ureter in 3 cases was treated endoscopically. An endoscopic procedure resolved 75% of recurrences. A high surgical risk patient who did not undergo open surgery died of recurrence.
Superficial transitional cell carcinoma of the intramural ureter is uncommon in the setting of multiple bladder tumors and recurrent bladder carcinoma. There was a 42.1% rate of ipsilateral recurrence and endoscopic treatment allowed us to preserve 89.5% of the involved renal units. Closer followup of the urinary tract must be performed since these tumors have a higher incidence of upper urinary tract recurrence.
我们分析经尿道切除术治疗壁内段远端输尿管浅表性移行细胞癌的演变情况。
共有19例患者接受了壁内段远端输尿管经尿道切除术,平均随访57个月。所有病例均诊断为浅表性移行细胞癌,除2例患者外均有膀胱肿瘤病史。上尿路随访包括每6个月进行一次排泄性尿路造影,对诊断存疑或细胞学检查阳性的病例进行输尿管肾镜检查。
病理检查显示,壁内肿瘤中42%为Ta期疾病,31.5%为T1期,26.3%为Tx期。8例患者(42.1%)出现上尿路复发,其中5例(62.5%)累及远端输尿管。3例远端输尿管非肿瘤性狭窄接受了内镜治疗。内镜手术解决了75%的复发问题。一名手术风险高且未接受开放手术的患者死于复发。
壁内段输尿管浅表性移行细胞癌在多发膀胱肿瘤和复发性膀胱癌的情况下并不常见。同侧复发率为42.1%,内镜治疗使我们能够保留89.5%的受累肾单位。由于这些肿瘤上尿路复发的发生率较高,因此必须对尿路进行更密切的随访。